A new trading day began on November 20, 2023, with Bristol-Myers Squibb Co. (NYSE: BMY) stock priced at $48.78, down -3.82% from the previous day of trading. During the day, the shares moved up to $50.17 and dropped to $48.42 before settling in for the closing price of $50.84. BMY’s price has ranged from $49.49 to $81.43 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 19.14% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -2.04%. With a float of $2.03 billion, this company’s outstanding shares have now reached $2.10 billion.
In an organization with 34300 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +57.39, operating margin of +20.08, and the pretax margin is +16.71.
Bristol-Myers Squibb Co. (BMY) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Bristol-Myers Squibb Co. is 0.07%, while institutional ownership is 78.79%. The most recent insider transaction that took place on Aug 24, was worth 1,101,642. In this transaction EVP, Chief Human Resources of this company sold 17,986 shares at a rate of $61.25, taking the stock ownership to the 27,868 shares. Before that another transaction happened on Aug 03, when Company’s EVP, Chief Research Officer sold 732 for $61.14, making the entire transaction worth $44,754. This insider now owns 6,584 shares in total.
Bristol-Myers Squibb Co. (BMY) Latest Financial update
In its latest quarterly report, released on 9/29/2023, the company reported earnings of $1.83 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of +13.71 while generating a return on equity of 18.88. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.86 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.25% during the next five years compared to 37.06% growth over the previous five years of trading.
Bristol-Myers Squibb Co. (NYSE: BMY) Trading Performance Indicators
Here are Bristol-Myers Squibb Co.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.21. Likewise, its price to free cash flow for the trailing twelve months is 8.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.94, a number that is poised to hit 1.76 in the next quarter and is forecasted to reach 7.34 in one year’s time.
Technical Analysis of Bristol-Myers Squibb Co. (BMY)
Let’s dig in a bit further. During the last 5-days, its volume was 15.61 million. That was better than the volume of 9.74 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 26.53%. Additionally, its Average True Range was 1.26.
During the past 100 days, Bristol-Myers Squibb Co.’s (BMY) raw stochastic average was set at 2.83%, which indicates a significant decrease from 9.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.34% in the past 14 days, which was higher than the 21.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $55.36, while its 200-day Moving Average is $63.33. However, in the short run, Bristol-Myers Squibb Co.’s stock first resistance to watch stands at $49.91. Second resistance stands at $50.91. The third major resistance level sits at $51.66. If the price goes on to break the first support level at $48.16, it is likely to go to the next support level at $47.41. The third support level lies at $46.41 if the price breaches the second support level.
Bristol-Myers Squibb Co. (NYSE: BMY) Key Stats
With a market capitalization of 99.50 billion, the company has a total of 2,034,758K Shares Outstanding. Currently, annual sales are 46,159 M while annual income is 6,327 M. The company’s previous quarter sales were 10,966 M while its latest quarter income was 1,928 M.